Management to Hold Fiscal Second Quarter 2023 Conference Call on Wednesday, November 30, 2022, at 8:30 AM ET
TORONTO, Nov. 28, 2022 (GLOBE NEWSWIRE) — Field Trip Health & Wellness Ltd. (TSXV: FTHW) (the “Company” of “Field Trip”), a global leader in the delivery of psychedelic therapies, announced today that it now plans to release financial results for its fiscal 2023 second quarter for the three-month period ended September 30, 2022, after market close on Tuesday, November 29, 2022.
The Company will conduct a conference call and webcast to discuss its results the following morning, Wednesday, November 30, 2022 at 8:30 a.m. ET. The Company moved the call in order to accommodate investors following the Thanksgiving holiday in the U.S.
To access the call, please dial 1-877-407-9716 (within the U.S.) or 1-201-493-6779 (outside the U.S.) and provide conference ID 13734182. A live webcast of the conference call can be accessed via the Events and Presentations section of the Field Trip Health & Wellness Investor Relations website here.
For those unable to attend the live call, a telephonic replay will be available until 11:59 p.m. ET on Wednesday, December 14, 2022. To access the replay dial 1-844-512-2921 (within the U.S.) or 1-412-317-6671 (outside the U.S.) and provide conference ID 13734182. The webcast will be archived and available in the Events and Presentations section of the Field Trip Health & Wellness Investor Relations website approximately one hour after the conclusion of the live call.
About Field Trip Health & Wellness Ltd.
With a large global community of psychedelic-interested people, proprietary psychedelic therapies that generate transformative results for people in the treatment of mental health conditions and a brand and share of voice that is reaching millions of people, Field Trip is a center of gravity for the psychedelic renaissance.
Learn more at https://www.meetfieldtrip.com, https://www.fieldtriphealth.com and https://www.fieldtriphealth.nl.
Follow us on Twitter and Instagram: @fieldtriphealth
To receive company updates about Field Trip and to be added to the email distribution list please sign up here.
Download Field Trip’s app here.
Cautionary Note Regarding Forward-Looking Information
This release includes forward-looking information (within the meaning of Canadian securities laws and within the meaning of the United States Private Securities Litigation Reform Act of 1995) regarding the Company and its business. Often but not always, forward-looking information can be identified by the use of words such as “expect”, “intends”, “anticipated”, “believes” or variations (including negative variations) of such words and phrases, or state that certain actions, events or results “may”, “could”, “would” or “will” be taken, occur or be achieved. Such statements are based on the current expectations and views of future events of the management of the Company and are based on assumptions and subject to risks and uncertainties. Although the management believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release may not occur and could differ materially as a result of known and unknown risk factors and uncertainties affecting the companies, including ability of Field Trip to realize its business plan, grow its clients base or app user base, uptake in existing or new programs by clinicians or patients, if any, results or ability to commercialize its research and cultivation business or uptake in any products developed thereby, acceptance of psychedelic treatments by clinicians, patients, and regulators, ability or effect of any clinical restructuring, the ability of Field Trip to realize on its business plan for broadened, holistic approach to mental health and wellbeing and/or future changes in regulatory regimes which govern Field Trip’s business. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended, including those risk factors contained in the Company’s public filings at www.sedar.com. Accordingly, readers should not place undue reliance on any forward-looking statements or information. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Company does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. Additional information relating to the Company, can be located on the SEDAR website at www.sedar.com.
Neither TSX Venture Exchange, or its Regulation Services Provider, have approved the contents of this release or accept responsibility for the adequacy or accuracy of this release.
CONTACTS:
Field Trip Health & Wellness:
Ronan Levy
ronan@fieldtriphealth.com
(416) 505-0929
Investor contacts:
Phil Carlson / Sophia Bashford
KCSA Strategic Communications
fieldtripIR@kcsa.com
(646) 573-0776 / (929) 246-7307
Media contacts:
Isabella Morreale
Autumn Communications
press@fieldtriphealth.com
(862) 579-7944
SOURCE Field Trip Health & Wellness Ltd.
Related Quotes
U.S. companies currently led or owned by Indians have a market capitalization of more than $6 trillion. Their secret? Family and education.
New York City REIT Inc. (NYSE: NYC) slumped to even lower lows this week and now trades below $2 after going for $13 as recently as April. Many real estate investment trusts (REITs) have had a challenging year with the Federal Reserve steadily taking interest rates higher. Few, however, have experienced the relentless selling of this REIT. New York City REIT invests in properties in all five boroughs of the Big Apple, but most of the portfolio is concentrated in Manhattan. Funds from operations
Despite being an active buyer this year, Buffett's company Berkshire Hathaway also sold several of its holdings as it repositioned its portfolio.
Here are attractive choices for retirees and others who live off the income that their investments generate.
With a significant portion of its assets being contracted by shippers for the long term, Enbridge's (ENB) business model is less exposed to volatility in oil and gas prices.
Our 10 favorites from last year handily beat the market. Why we now like Alphabet, Bank of America, Medtronic, and seven others.
With their total returns being impressively better than the broader market this year, investors might want to consider these equities for 2023 as well.
Rivian (NASDAQ: RIVN) is one of the most talked about EV start-ups to hit the market in the past decade, but it hasn't done a lot to add value for investors. The hard truth is that it may be a while before Rivian is a profitable company. Using Tesla (NASDAQ: TSLA) as a proxy you can see below that Tesla wasn't generating positive free cash flow until 2019, nine years after it went public.
Learn the difference between the GOOG and GOOGL stock ticker symbols for Alphabet (the company formerly known as Google).
Stocks saw out the week on the backfoot once again. Initially buoyed at the start of the week by the better-than-expected inflation data, come Wednesday and the Fed signaling rates are set to go higher until it is clear inflation has been tamed, the mood soured again, shifting back to the bearish trends on offer most of the year. So, these are uncertain times. Volatility is the ruling force in the markets, and investors are looking for some signal that will indicate just which stocks are attract
In this article, we take a look at 10 best cheap stocks to buy now for long term. If you want to see more best cheap stocks to buy now for long term, go directly to 5 Best Cheap Stocks to Buy Now for Long Term. To many investors, a cheap stock isn’t a stock […]
Bernstein highlights three semiconductor companies that the firm says have the best product outlooks.
(Bloomberg) — Hedge fund manager Bill Harnisch, who has scored a 29% return this year, credits most of the success to a prescient call on inflation 15 months ago. If his take on consumer prices turns out to be correct again, stocks may go nowhere in coming years.Most Read from BloombergHarry and Meghan Aren't Doing Themselves Any FavorsUkraine Latest: Germany Says No Ceasefire on Russian TermsVerizon Lost Its Network Superiority — Now It’s Paying the PriceReal-Money Funds Dump $100 Billion of S
Entrepreneurs sell out stock eventually, and Tesla CEO Elon Musk is no different. But he's still firmly in control of the company he co-founded.
In this article, we discuss Jim Cramer’s favorite dividend aristocrats. If you want to see more stocks in this selection, check out Jim Cramer’s 5 Favorite Dividend Aristocrats. Jim Cramer, the host of Mad Money on CNBC and an anchor on Squawk on the Street, is one of the most followed television personalities commenting on […]
When a loved one passes away, it can be an emotional experience. Unfortunately, handling the deceased's finances can add to this stress. While most people know that you need to file a final tax return for the deceased, most people … Continue reading → The post Income in Respect of a Decedent (IRD) appeared first on SmartAsset Blog.
Because of that, there are some real bargains out there for passive income-seeking investors. Three dividend-paying stocks a few Fool.com contributors think look extremely attractive following this year's sell-off are 3M (NYSE: MMM), Energy Transfer (NYSE: ET), and Brookfield Infrastructure Partners (NYSE: BIPC) (NYSE: BIP). Because of that, they could supply investors with lots of passive income in 2023 and beyond.
A bad week for the market. Here's the bottom line.
Medical Properties (MPW) closed at $11.39 in the latest trading session, marking a -1.98% move from the prior day.
Goldman Sachs Group Inc. plans to lay off up to 4,000 employees, or about 8% of its workforce, The New York-based investment bank also plans to cut, and in some cases eliminate, the annual bonuses of underperforming employees, according to The Wall Street Journal, citing unnamed sources familiar with the matter. Despite the job cuts, the bank will still have more employees than it did before the pandemic, the newspaper said. Goldman (NYSE: GS) employed more than 49,000 in September, compared with 38,000 at the end of 2019.
